Aerosol formulation for inhalation, containing an anticholinergic agent

Details for Australian Patent Application No. 2004275490 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Boeck, Georg; Schmidt, Friedrich

Agent Davies Collison Cave

Pub. Number AU-B-2004275490

PCT Pub. Number WO2005/030211

Priority 103 45 065.3 26.09.03 DE

Filing date 21 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 4 March 2010

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

11 May 2006 PCT application entered the National Phase

  PCT publication WO2005/030211 Priority application(s): WO2005/030211

4 March 2010 Application Accepted

  Published as AU-B-2004275490

1 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275500-Identification of tumour-associated cell surface antigens for diagnosis and therapy

2004275488-Pyridine derivatives and use thereof as urotensin II antagonists